The time is here to list AusBiotech's New Year's resolutions, which will buoy and grow the Australian biotechnology industry, support your success and ensure 2015 is the best year yet.

Antibody provider Cell Signaling Technology (CST) has entered into a strategic partnership to supply antibodies for use in Dako companion diagnostics products. [ + ]

LBT Innovations (ASX:LBT) is set to lose a substantial source of income, with licensee bioMérieux planning to terminate its agreement with the Australian lab technology provider.

Consulting company Clinical Network Services (CNS) has established an office in the US to allow it to support clients seeking to engage with the FDA.

Sirtex Medical (ASX:SRX) has now recruited over 1000 patients for its three concurrent trials of its liver cancer treatment SIR-Spheres microspheres.

The Australian Institute of Marine Science will start the year off with a new chair and three new members for its council. [ + ]

A minimally invasive procedure is now available to Australian patients suffering from obstructive lung diseases such as emphysema. An alternative to surgical resection of the most diseased part of a lung, endoscopic lung volume reduction (ELVR) involves having an umbrella-shaped, one-way valve endoscopically positioned into the airway serving the affected lobe. [ + ]

Rotaviruses invade cells of the gastrointestinal tract through carbohydrate receptors, findings that may lead to new ways of preventing this contagious childhood disease. [ + ]

Minister for Education and Training Christopher Pyne has announced a new fellowship scheme to expand research capacity in dementia. The NHMRC-ARC Dementia Research Development Fellowships Scheme provides opportunities for postdoctoral researchers to engage in advanced training in the health, medical, fundamental sciences, social, economic and cultural fields relevant to dementia. [ + ]

The Australian Academy of Science has welcomed last month's announcement that Ian Macfarlane is now the Minister for Industry and Science - a move Academy President Professor Andrew Holmes hopes will be more than a change in title. [ + ]

Researchers have used the most powerful computer in Japan to explore a process observed in both bubbly beverages as well as scientific systems including spin systems, foams and metallic alloys. [ + ]

Researchers from the University of Cambridge and the University of Technology, Sydney (UTS) are studying the function of a newly discovered family of proteins associated with archaea - microorganisms believed to be amongst the oldest lifeforms on Earth. [ + ]

We are taking a break over Christmas and will be back in early January to keep you up to date with the latest in life science news. [ + ]

Applications for round three of the NSW Medical Devices Fund have officially opened. The fund is a $5 million per annum technology developments and commercialisation program, with $6.7 million available for the 2015-2016 funding round. [ + ]

The US FDA has approved Cerus Corporation's Intercept Blood System for plasma - said to be the first pathogen reduction system for use by blood establishments in the preparation of plasma in order to reduce the risk of transfusion-transmitted infections. [ + ]